Editorial

» disease/medicine, techniques and cancer

Most Recent

image: To Each His Own

To Each His Own

By | April 1, 2015

Cancer treatment becomes more and more personal.

0 Comments

image: Bad Raps

Bad Raps

By | December 1, 2014

Understanding animal diseases—for their sake and for ours

0 Comments

image: Eye Spies

Eye Spies

By | October 1, 2014

An issue highlighting advances in vision research

0 Comments

image: Small Packages

Small Packages

By | August 1, 2014

When proverbs come true

0 Comments

image: Your Brain on Art

Your Brain on Art

By | May 1, 2014

A new scientific discipline investigates the neurology underlying the experience and the creation of beauty.

0 Comments

image: Search and Destroy

Search and Destroy

By | April 1, 2014

Turning a patient’s immune cells into cancer-fighting weapons

0 Comments

image: An Offensive Playbook

An Offensive Playbook

By | February 1, 2014

Developing nonaddictive drugs to combat pain

0 Comments

image: Exploring the Neuron Forest

Exploring the Neuron Forest

By | November 1, 2013

Innovations in imaging techniques and genetic sequencing take neuroscience to a new level.

0 Comments

image: Get a Whiff of This

Get a Whiff of This

By | October 1, 2013

An issue devoted to the latest research on how smells lead to actions

2 Comments

image: You Are <em>When</em> You Eat

You Are When You Eat

By | September 1, 2013

Circadian time zones and metabolism

0 Comments

Popular Now

  1. UC Berkeley Receives CRISPR Patent in Europe
    Daily News UC Berkeley Receives CRISPR Patent in Europe

    The European Patent Office will grant patent rights over the use of CRISPR in all cell types to a University of California team, contrasting with a recent decision in the U.S.

  2. DNA Replication Errors Contribute to Cancer Risk
  3. Should Healthy People Have Their Exomes Sequenced?
    Daily News Should Healthy People Have Their Exomes Sequenced?

    With its announced launch of a whole-exome sequencing service for apparently healthy individuals, Ambry Genetics is the latest company to enter this growing market. But whether these services are useful for most people remains up for debate.  

  4. Rethinking a Cancer Drug Target
    Daily News Rethinking a Cancer Drug Target

    The results of a CRISPR-Cas9 study suggest that MELK—a protein thought to play a critical role in cancer—is not necessary for cancer cell survival.

Business Birmingham